Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: The "BAV for life" experience.

Attisano T, Silverio A, Stabile E, Briguori C, Tuccillo B, Scotto Di Uccio F, Di Lorenzo E, Tesorio T, Giordano A, Calabrò P, Cappelli Bigazzi M, Golino P, Scherillo M, Vigorito F, Quaranta G, Esposito G, Mauro C, Musumeci G, Tarantini G, Galasso G; BAV for Life Investigators.

Catheter Cardiovasc Interv. 2018 Aug 25. doi: 10.1002/ccd.27820. [Epub ahead of print]

PMID:
30144332
2.

Lights and shadows of long-term dual antiplatelet therapy in "real life" clinical scenarios.

Scherillo M, Cirillo P, Formigli D, Bonzani G, Calabrò P, Capogrosso P, Caso P, Esposito G, Farina R, Golino P, Lanzillo T, Mascia F, Mauro C, Piscione F, Sibilio G, Tuccillo B, Villari B, Trimarco B.

J Thromb Thrombolysis. 2018 Nov;46(4):559-569. doi: 10.1007/s11239-018-1707-1.

PMID:
29943351
3.

Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group".

Scherillo M, Cirillo P, Formigli D, Bonzani G, Calabrò P, Capogrosso P, Farina R, Lanzillo T, Mascia F, Mauro C, Tuccillo B, Bellis A, Bianchi R, Cimmino G, Piro O, Ravera A, Scotto di Uccio F, Tammaro P, Vetrano A, Trimarco B.

Angiology. 2017 Aug;68(7):598-607. doi: 10.1177/0003319716676721. Epub 2016 Nov 12.

PMID:
28660806
4.

Right ventricular lead placement and ventricular dyssynchrony in a pacemaker population: An acute analysis from the evaluation of apical and non-apical position (right pace) study.

Muto C, Calvi V, Botto GL, Pecora D, Zuccaro LM, Costa A, Ciaramitaro G, Airò Farulla R, Nigro G, Tuccillo B, Racheli M, Lilli A, Reggiani A, Malacrida M, Valsecchi S, Maglia G.

Int J Cardiol. 2016 Dec 15;225:296-299. doi: 10.1016/j.ijcard.2016.09.112. Epub 2016 Oct 3. No abstract available.

PMID:
27744206
5.

Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study.

De Luca L, Leonardi S, Smecca IM, Formigli D, Lucci D, Gonzini L, Tuccillo B, Olivari Z, Gulizia MM, Bovenzi FM, De Servi S; EYESHOT Investigators.

Eur Heart J Cardiovasc Pharmacother. 2015 Jul;1(3):168-78. doi: 10.1093/ehjcvp/pvv006. Epub 2015 Feb 24.

PMID:
27533991
6.

Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study.

De Luca L, Leonardi S, Cavallini C, Lucci D, Musumeci G, Caporale R, Abrignani MG, Lupi A, Rakar S, Gulizia MM, Bovenzi FM, De Servi S; EYESHOT Investigators.

Eur Heart J Acute Cardiovasc Care. 2015 Oct;4(5):441-52. doi: 10.1177/2048872614560505. Epub 2014 Nov 20.

PMID:
25414322
7.

Gender-related safety and efficacy of cardiac resynchronization therapy.

Schuchert A, Muto C, Maounis T, Frank R, Ella RO, Polauck A, Padeletti L; MASCOT Study Group.

Clin Cardiol. 2013 Nov;36(11):683-90. doi: 10.1002/clc.22203. Epub 2013 Sep 17.

8.

A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).

Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C; EXECUTIVE Trial Investigators.

JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18.

9.

A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.

Muto C, Solimene F, Gallo P, Nastasi M, La Rosa C, Calvanese R, Iengo R, Canciello M, Sangiuolo R, Diemberger I, Ciardiello C, Tuccillo B.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):538-45. doi: 10.1161/CIRCEP.113.000135. Epub 2013 Apr 16.

PMID:
23592833
10.

Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.

Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Vinereanu D, Ambrosio G, Zava D; SMILE-4 Working Party.

J Hypertens. 2013 Jun;31(6):1256-64. doi: 10.1097/HJH.0b013e3283605cd8.

PMID:
23552127
11.

One-year outcome after CRT implantation in NYHA class IV in comparison to NYHA class III patients.

Schuchert A, Muto C, Maounis T, Frank R, Ella RO, Polauck A, Padeletti L; Mascot Study Group.

Clin Res Cardiol. 2013 Jul;102(7):505-11. doi: 10.1007/s00392-013-0558-1. Epub 2013 Mar 31.

PMID:
23543129
12.

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.

Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, Padeletti L; MASCOT study group.

Europace. 2013 Jan;15(1):71-6. doi: 10.1093/europace/eus247. Epub 2012 Aug 26.

PMID:
22927665
14.

A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients.

Galzerano D, Di Michele S, Paolisso G, Tuccillo B, Lama D, Carbotta S, Cittadini A, Tedesco MA, Gaudio C.

J Renin Angiotensin Aldosterone Syst. 2012 Dec;13(4):496-503. doi: 10.1177/1470320312443909. Epub 2012 Apr 30.

PMID:
22546623
15.

Subclinical atrial fibrillation and the risk of stroke.

Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators.

N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575. Erratum in: N Engl J Med. 2016 Mar 10;374(10):998.

PMID:
22236222
16.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators.

N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13.

17.

Presence of left ventricular contractile reserve predicts midterm response to cardiac resynchronization therapy--results from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) trial.

Muto C, Gasparini M, Neja CP, Iacopino S, Davinelli M, Zanon F, Dicandia C, Distefano G, Donati R, Calvi V, Denaro A, Tuccillo B.

Heart Rhythm. 2010 Nov;7(11):1600-5. doi: 10.1016/j.hrthm.2010.07.036. Epub 2010 Aug 3.

PMID:
20691283
18.

A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.

Ribichini F, Ansalone G, Bartorelli A, Beqaraj F, Berni A, Colangelo S, D'Amico M, Della Rovere F, Fiscella A, Gabrielli G, Indolfi C, La Vecchia L, Loschiavo P, Marinoni G, Marzocchi A, Milazzo D, Romano M, Sangiorgio P, Sheiban I, Tamburino C, Tuccillo B, Villani R, Cappi B, Quijada MJ, Vassanelli C; EXECUTIVE Trial Investigators.

J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):299-309. doi: 10.2459/JCM.0b013e3283331e69.

PMID:
20090550
19.

Quadricuspid pulmonary valve diagnosed by cardiac magnetic resonance.

Ascione L, lengo R, Tuccillo B, D'Andrea A, De Michele M, Porto A, Ronza F, Del Viscovo L.

J Cardiovasc Med (Hagerstown). 2009 Dec;10(12):944-5. No abstract available.

PMID:
20054880
20.

Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion.

Piscione F, Danzi GB, Cassese S, Esposito G, Cirillo P, Galasso G, Rapacciuolo A, Leosco D, Briguori C, Varbella F, Tuccillo B, Chiariello M.

Catheter Cardiovasc Interv. 2010 Apr 1;75(5):715-21. doi: 10.1002/ccd.22292.

PMID:
19937780

Supplemental Content

Loading ...
Support Center